menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Pfizer cranks up revenue outlook amid Paxlovid sales bump

    FIERCE PHARMA

    Pfizer’s Paxlovid Ineffective Against Long COVID Using 15-Day Regimen: Study

    BIOSPACE

    Pfizer`s Paxlovid fails as 15-day treatment for long COVID, study finds

    REUTERS

    FDA blesses Pfizer with priority review voucher for Paxlovid nod

    FIERCE PHARMA

    Japan`s Shionogi says COVID treatment did not meet endpoint in late-stage trial

    REUTERS

    Ex-Pfizer employee convicted of insider trading on COVID drug trial

    REUTERS

    Millions of Paxlovid doses are headed for the bin in Europe

    FIERCE PHARMA

    Pfizer sets Paxlovid price at $1,390 for five-day course

    ENDPTS

    Pfizer slashes revenue forecast on lower COVID sales, will cut costs

    REUTERS

    About 250,000 courses of COVID pill Paxlovid being administered per week

    REUTERS

    US NIH launches long-COVID trials of Pfizer`s Paxlovid, other therapies

    REUTERS

    Pfizer’s COVID-19 oral anti-viral available to more Australians Pharma Benefits

    NATION ALTRIBUNE

    SEC charges former Pfizer employee with insider trading

    FIERCE PHARMA

    Former Pfizer employee charged with insider trading unreleased Covid pill data

    CNBC

    Pfizer`s Paxlovid (nirmatrelvir, ritonavir) Approved In Europe

    EMA

    US FDA approves first oral anti-viral for treatment of COVID-19 in adults

    BIOSPECTRUM ASIA

    Pfizer`s COVID antiviral Paxlovid gains full US approval

    REUTERS

    Pfizer`s Paxlovid pulls off a surprise with $4.1B in sales in Q1

    FIERCE PHARMA

    Pfizer, Merck trim prices in China for Paxlovid, molnupiravir

    REUTERS

    New Yale study evaluates PAXLOVID`s use in Long COVID recovery

    PR NEWSWIRE

    US FDA advisers vote in favor of full approval for Pfizer`s COVID pill Paxlovid

    REUTERS

    Pfizer to replace migraine drug packaging over child safety concerns

    REUTERS

    Data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults

    CNBC

    Pfizer`s Paxlovid gets March FDA advisory meeting to discuss full approval

    ENDPTS

    Trio of COVID-19 treatments receive NICE nod

    PHARMATIMES

    Pfizer launches new branded Paxlovid ad for COVID

    FIERCE PHARMA

    FDA axes requirement for positive Covid test before Paxlovid use

    ENDPTS

    With big discounts, 100+ drugs win national coverage in China

    FIERCE PHARMA

    Medscape Survey Finds Reasons Paxlovid Is Underprescribed For Those 65 And Older

    PR NEWSWIRE

    Junshi Biosciences Announces NEJM Publication of Results of Ph3 Study of VV116

    GLOBENEWSWIRE

    India-based Hetero`s Paxlovid generic gets WHO backing

    REUTERS

    Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment

    EXPRESSPHARMA

    Drug price group slashes suggested price of Pfizer COVID treatment by 80%

    REUTERS

    US set to pay nearly $2B for Pfizer`s Covid-19 treatment Paxlovid in 2023

    ENDPTS

    Lawmakers press Pfizer on fair commercial price for Comirnaty

    FIERCEPHARMA

    Pfizer says it is working to improve supply of COVID drug Paxlovid in China

    REUTERS

    U.S. to pay Pfizer nearly $2 bln for more Paxlovid courses in 2023

    REUTERS

    China NMPA grants IND clearance for trial of Ascletis’ Covid-19 drug

    CLINICALTRIALSARENA

    Pfizer`s hunt for Paxlovid sibling leads to low-profile biotech

    FIERCEBIOTECH

    Could Paxlovid treat long Covid? Major new study aims to find out

    NBCNEWS

    Pfizer Europe`s Paxlovid (nirmatrelvir) Receives Approval in the Europe

    EMA

    Pfizer`s Paxlovid access questioned ahead of WTO patent talks

    FIERCEPHARMA

    NICE recommends Pfizer’s Paxlovid on NHS

    PHARMATIMES

    Covid-19 rebound may be more common in people who take Paxlovid, early study

    EDITION

    U.S. CDC director experiences COVID rebound after taking Pfizer`s Paxlovid

    REUTERS

    NIH to study Pfizer`s Paxlovid in long Covid demand infections continue to fall

    ENDPTS

    Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir

    JACC

    Pfizer to deliver up to six million courses of Paxlovid to Global Fund

    PHARMACEUTICAL-TECHNOLOGY

    Paxlovid Significantly Reduces COVID-19 Hospitalizations and Deaths

    PRNEWSWIRE

    Zenara Pharma Launches Generic Of Paxlovid For COVID-19 In India

    OUTLOOKINDIA

    Study: Pfizer COVID pill showed no benefit in younger adults

    HEALTH ET

    Pfizer`s Paxlovid only helped seniors avoid hospitalization and death: NEJM

    ENDPTS

    Pfizer tabs controversial Chinese firm Huahai to make Paxlovid

    FIERCEPHARMA

    At FDA request, Pfizer to examine a longer course of Paxlovid

    FIERCEPHARMA

    FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

    REUTERS

    Dr. B Raises $8 Million for New Telehealth Service

    BUSINESSWIRE

    Pfizer quarterly sales surge to record high, driven by Paxlovid

    CNBC

    Pfizer poised to maintain pandemic sales dominance

    FIERCEPHARMA

    Zenara pharma to launch generic Paxlovid soon

    ECONOMIC TIMES

    Paxlovid sales are due to slip from 2023 on, GlobalData predicts

    FIERCEPHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.